Table 5.
Treatment outcomes according to WHO (n ([%])9
| Total including MDR-TB | Total excluding MDR-TB | Definition9 | |||||
|---|---|---|---|---|---|---|---|
| Total | Adults | Children | Total | HIV-uninfected | HIV-infected | ||
| N = 201 | N = 170 | N = 31 | N = 193 | N = 108 | N = 67 | ||
| Treatment success | 106 (52.7) | 90 (52.9) | 16 (51.6) | 106 (54.9) | 64 (59.3) | 30 (44.8) | Total of “cured” and “treatment completed” |
| Cured | 15 (7.5) | 13 (7.6) | 2 (6.5) | 15 (7.8) | 10 (9.3) | 4 (6.0) | Smear or culture negative in the last month of treatment and on one previous occasion |
| Treatment completed | 91 (45.3) | 77 (45.3) | 14 (45.2) | 91 (47.2) | 54 (50.0) | 26 (38.8) | No evidence of failure but not meeting criteria for “cured” |
| Treatment failed | 5 (2.5) | 4 (2.4) | 1 (3.2) | 5 (2.6) | 3 (2.8) | 2 (3.0) | Smear or culture positive at month 5 or later |
| Died | 21 (10.4)* | 20 (11.8) | 1 (3.2) | 17 (8.8) | 0 | 17 (25.4) | Death for any reason |
| Lost to follow-up | 34 (16.9) | 26 (15.3) | 8 (25.8) | 34 (17.6) | 21 (19.4) | 12 (17.9) | Treatment interruption for two consecutive months or more |
| Not evaluated | 35 (17.4)† | 30 (17.6) | 5 (16.1) | 31 (16.1) | 20 (18.5) | 6 (9.0) | Treatment outcome unknown |
HIV = human immunodeficiency virus; MDR = multidrug resistance; TB = tuberculosis; WHO = World Health Organization.
*
Including 4 (2.0%) patients with MDR-TB.
†
Of the patients, 4 (2.0%) with MDR-TB were classified as not evaluated since none of them received appropriate second-line treatment.